Rhumbline Advisers Has $194 Million Position in CME Group Inc. $CME

Rhumbline Advisers cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 0.1% during the 2nd quarter, Holdings Channel reports. The fund owned 703,865 shares of the financial services provider’s stock after selling 684 shares during the period. Rhumbline Advisers’ holdings in CME Group were worth $193,999,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in shares of CME Group by 1.5% during the 2nd quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after purchasing an additional 532,549 shares in the last quarter. Geode Capital Management LLC increased its position in CME Group by 3.6% in the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after buying an additional 319,899 shares in the last quarter. Raymond James Financial Inc. raised its stake in CME Group by 9.7% during the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock worth $1,091,401,000 after buying an additional 363,130 shares during the period. Vontobel Holding Ltd. boosted its holdings in CME Group by 3.0% in the second quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock worth $804,823,000 after acquiring an additional 84,005 shares in the last quarter. Finally, Fiera Capital Corp grew its stake in CME Group by 1.6% in the second quarter. Fiera Capital Corp now owns 2,790,592 shares of the financial services provider’s stock valued at $769,143,000 after acquiring an additional 44,377 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Transactions at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William R. Shepard bought 262 shares of CME Group stock in a transaction dated Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have sold 14,043 shares of company stock worth $3,791,486. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday, October 14th. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Barclays dropped their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group boosted their target price on shares of CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a research report on Thursday, October 23rd. Eight analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and an average target price of $287.65.

CME Group Price Performance

Shares of NASDAQ:CME opened at $273.09 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $98.48 billion, a PE ratio of 26.46, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. The stock’s fifty day simple moving average is $268.74 and its two-hundred day simple moving average is $272.78. CME Group Inc. has a 1-year low of $224.62 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.68 EPS. As a group, analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio is presently 48.45%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.